Analytics of the Cost Effectiveness and Real-Time Health Risk Assessments for Pharmacy-Based Preventive Health Services

Abstract

More patient-centered care and participation in managing chronic illnesses are features of the modern pharmacist's task, which has evolved substantially in recent years. Still, the issue of whether or not pharmacists are cost-effective in diabetes care persists. Cost-effectiveness analyses (CEA) have emerged as a crucial tool when making informed decisions about healthcare delivery. Patients' present health status, past medical history (personal and family), and lifestyle variables influencing their health are all part of a health risk assessment (HRA). Hence, this study proposed a Cost-Effectiveness Analysis of Pharmacy-based Preventive Health Services (CEA-PBPHS) model for real-time health risk assessment. Nowadays, medical professionals place a greater emphasis on preventative health care. This research aims to examine the potential impact of risk assessment tools on males past due for a physical examination and evaluate the return on investment (ROI) for community pharmacists who provide this service for free. More cost-efficient or cost-saving than conventional treatment is pharmacist engagement in diabetes management due to better glucose control, higher patient compliances, and lower risks of medication-related issues. The experimental outcomes demonstrate that the suggested CEA-PBPHS model increases the health risk assessment ratio by 98.9%, the personalized health service ratio by 97.5% and the cost-effectiveness analysis ratio by 98.3% compared to other existing models.